Key Financial Data Of Group

Perseus Proteomics Inc. - Filing #7585091

Concept 2022-04-01 to
2022-09-30
As at
2022-09-30
2022-07-01 to
2022-09-30
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2021-09-30
2021-04-01 to
2021-09-30
2021-07-01 to
2021-09-30
Key financial data of group
Business results of group
Net sales
47,500,000 JPY
71,932,000 JPY
29,437,000 JPY
Ordinary profit (loss)
-288,604,000 JPY
-481,681,000 JPY
-263,757,000 JPY
Net assets
2,799,555,000 JPY
3,152,154,000 JPY
3,479,539,000 JPY
Total assets
2,889,393,000 JPY
3,300,530,000 JPY
3,550,390,000 JPY
Basic earnings (loss) per share
-30.87
-13.84
-54.47
-26.77
-11.36
Diluted earnings per share
Equity-to-asset ratio
0.9653 xbrli:pure
0.9550 xbrli:pure
0.9794 xbrli:pure
Net cash provided by (used in) operating activities
-255,906,000 JPY
-476,842,000 JPY
-205,161,000 JPY
Net cash provided by (used in) investing activities
-156,007,000 JPY
-33,868,000 JPY
-6,409,000 JPY
Net cash provided by (used in) financing activities
-20,000 JPY
2,647,548,000 JPY
2,647,548,000 JPY
Cash and cash equivalents
2,820,171,000 JPY
3,214,852,000 JPY
3,506,229,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.